Industry Growth Insights published a new data on “Assistive Reproductive Market”. The research report is titled “Assistive Reproductive Market research by Types (In-vitro fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other, Assistive Reproductiv), By Applications (Fertility Clinics, IVF Center, Hospital), By Players/Companies Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura, Assistive Reproductiv”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Assistive Reproductive Market Research Report
By Type
In-vitro fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other, Assistive Reproductiv
By Application
Fertility Clinics, IVF Center, Hospital
By Companies
Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura, Assistive Reproductiv
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Assistive Reproductive Market Report Segments:
The global Assistive Reproductive market is segmented on the basis of:
Types
In-vitro fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other, Assistive Reproductiv
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Clinics, IVF Center, Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cooper Surgical
- Hamilton Thorne
- FUJIFILM Irvine Scientific
- Nidacon International
- Vitrolife AB
- Merck
- INVO Bioscience
- IVFtech
- Gonagen Medikal
- Cook Medical
- CellCura
- Assistive Reproductiv
Highlights of The Assistive Reproductive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- In-vitro fertilization (IVF)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Other
- Assistive Reproductiv
- By Application:
- Fertility Clinics
- IVF Center
- Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Assistive Reproductive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Assistive reproductive technologies (ART) are medical procedures or devices that help couples conceive a child. ART can include medications, surgery, and other treatments.
Some of the key players operating in the assistive reproductive market are Cooper Surgical, Hamilton Thorne, FUJIFILM Irvine Scientific, Nidacon International, Vitrolife AB, Merck, INVO Bioscience, IVFtech, Gonagen Medikal, Cook Medical, CellCura, Assistive Reproductiv.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Assistive Reproductive Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Assistive Reproductive Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Assistive Reproductive Market - Supply Chain
4.5. Global Assistive Reproductive Market Forecast
4.5.1. Assistive Reproductive Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Assistive Reproductive Market Size (000 Units) and Y-o-Y Growth
4.5.3. Assistive Reproductive Market Absolute $ Opportunity
5. Global Assistive Reproductive Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Assistive Reproductive Market Size and Volume Forecast by Type
5.3.1. In-vitro fertilization (IVF)
5.3.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
5.3.3. Frozen Embryo Replacement (FER)
5.3.4. Other
5.3.5. Assistive Reproductiv
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Assistive Reproductive Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Assistive Reproductive Market Size and Volume Forecast by Application
6.3.1. Fertility Clinics
6.3.2. IVF Center
6.3.3. Hospital
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Assistive Reproductive Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Assistive Reproductive Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Assistive Reproductive Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Assistive Reproductive Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Assistive Reproductive Demand Share Forecast, 2019-2026
9. North America Assistive Reproductive Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Assistive Reproductive Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Assistive Reproductive Market Size and Volume Forecast by Application
9.4.1. Fertility Clinics
9.4.2. IVF Center
9.4.3. Hospital
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Assistive Reproductive Market Size and Volume Forecast by Type
9.7.1. In-vitro fertilization (IVF)
9.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
9.7.3. Frozen Embryo Replacement (FER)
9.7.4. Other
9.7.5. Assistive Reproductiv
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Assistive Reproductive Demand Share Forecast, 2019-2026
10. Latin America Assistive Reproductive Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Assistive Reproductive Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Assistive Reproductive Market Size and Volume Forecast by Application
10.4.1. Fertility Clinics
10.4.2. IVF Center
10.4.3. Hospital
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Assistive Reproductive Market Size and Volume Forecast by Type
10.7.1. In-vitro fertilization (IVF)
10.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
10.7.3. Frozen Embryo Replacement (FER)
10.7.4. Other
10.7.5. Assistive Reproductiv
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Assistive Reproductive Demand Share Forecast, 2019-2026
11. Europe Assistive Reproductive Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Assistive Reproductive Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Assistive Reproductive Market Size and Volume Forecast by Application
11.4.1. Fertility Clinics
11.4.2. IVF Center
11.4.3. Hospital
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Assistive Reproductive Market Size and Volume Forecast by Type
11.7.1. In-vitro fertilization (IVF)
11.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
11.7.3. Frozen Embryo Replacement (FER)
11.7.4. Other
11.7.5. Assistive Reproductiv
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Assistive Reproductive Demand Share, 2019-2026
12. Asia Pacific Assistive Reproductive Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Assistive Reproductive Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Assistive Reproductive Market Size and Volume Forecast by Application
12.4.1. Fertility Clinics
12.4.2. IVF Center
12.4.3. Hospital
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Assistive Reproductive Market Size and Volume Forecast by Type
12.7.1. In-vitro fertilization (IVF)
12.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
12.7.3. Frozen Embryo Replacement (FER)
12.7.4. Other
12.7.5. Assistive Reproductiv
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Assistive Reproductive Demand Share, 2019-2026
13. Middle East & Africa Assistive Reproductive Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Assistive Reproductive Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Assistive Reproductive Market Size and Volume Forecast by Application
13.4.1. Fertility Clinics
13.4.2. IVF Center
13.4.3. Hospital
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Assistive Reproductive Market Size and Volume Forecast by Type
13.7.1. In-vitro fertilization (IVF)
13.7.2. Artificial Insemination-Intrauterine Insemination (AI-IUI)
13.7.3. Frozen Embryo Replacement (FER)
13.7.4. Other
13.7.5. Assistive Reproductiv
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Assistive Reproductive Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Assistive Reproductive Market: Market Share Analysis
14.2. Assistive Reproductive Distributors and Customers
14.3. Assistive Reproductive Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cooper Surgical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hamilton Thorne
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. FUJIFILM Irvine Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nidacon International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Vitrolife AB
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. INVO Bioscience
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. IVFtech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Gonagen Medikal
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cook Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CellCura
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Assistive Reproductiv
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
